NCT02408055View on ClinicalTrials.gov

ADME Study in Healthy Male Subjects With TA-8995

PHASE1CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

August 31, 2015

Study Completion Date

August 31, 2015

Conditions
Dyslipidemia
Interventions
DRUG

TA-8995

Trial Locations (1)

LS2 9LH

Covance Clinical Research Unit Ltd, Leeds

All Listed Sponsors
lead

Xention Ltd

INDUSTRY

NCT02408055 - ADME Study in Healthy Male Subjects With TA-8995 | Biotech Hunter | Biotech Hunter